- Investigator
- Gary P Wang
- Status
- Accepting Candidates
Research at a glance
Top areas of exploration
- Sequence Analysis, DNA , 9 publications
- Phylogeny , 6 publications
- HIV Infections , 5 publications
- Dysbiosis , 5 publications
Research activity
Active clinical trials
Phase 1b/2a, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Escalation Study of the Safety, Tolerability, and Efficacy of Intravenous AP SA02 as an Adjunct to Best Available Antibiotic Therapy Compared to Best Available…
- Investigator
- Gary P Wang
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
Randomized, open-label, multi-center, comparative trial to assess the efficacy and safety in immunocompromised subjects with acyclovir resistant or acyclovir susceptible mucocutaneous HSV infection, treated with pritelivir 100 mg once daily…
- Investigator
- Gary P Wang
- Status
- Accepting Candidates
- Ages
- 16 Years - N/A
- Sexes
- All
My publications
Filter publications
69 publications
2023
Smoking-induced subgingival dysbiosis precedes clinical signs of periodontal disease.
Scientific reports
PubMed • Publisher's site2022
A randomized controlled trial to evaluate the effectiveness of a novel mouth rinse in patients with gingivitis.
BMC oral health
PubMed • Publisher's site2022
Correction to: Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
Drugs
PubMed • Publisher's site2022
Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
Drugs
PubMed • Publisher's site2022
Emulsification by vitamin E TPGS or Quillaja extract enhanced absorption of berberine without affecting its metabolism in humans.
Food & function
PubMed • Publisher's site